These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Contrast-Enhanced 3D-FLAIR Imaging of the Optic Nerve and Optic Nerve Head: Novel Neuroimaging Findings of Idiopathic Intracranial Hypertension. Golden E; Krivochenitser R; Mathews N; Longhurst C; Chen Y; Yu JJ; Kennedy TA AJNR Am J Neuroradiol; 2019 Feb; 40(2):334-339. PubMed ID: 30679213 [TBL] [Abstract][Full Text] [Related]
3. Apparent diffusion coefficient echoplanar imaging maps of the optic nerves in childhood idiopathic intracranial hypertension. Seber T; Bayram N; Bayram AK; Seber TU J Neuroimaging; 2021 Nov; 31(6):1184-1191. PubMed ID: 34388272 [TBL] [Abstract][Full Text] [Related]
4. Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension. Padhye LV; Van Stavern GP; Sharma A; Viets R; Huecker JB; Gordon MO J Neurol Sci; 2013 Sep; 332(1-2):80-5. PubMed ID: 23850064 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension. Eren Y; Kabatas N; Guven H; Comoglu S; Gurdal C Acta Neurol Belg; 2019 Sep; 119(3):351-357. PubMed ID: 30120685 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of idiopathic intracranial hypertension: A proposal for evidence-based diagnostic criteria. Korsbæk JJ; Jensen RH; Høgedal L; Molander LD; Hagen SM; Beier D Cephalalgia; 2023 Mar; 43(3):3331024231152795. PubMed ID: 36786317 [TBL] [Abstract][Full Text] [Related]
8. Correlation between papilledema grade and diffusion-weighted magnetic resonance imaging in idiopathic intracranial hypertension. Salvay DM; Padhye LV; Huecker JB; Gordon MO; Viets R; Sharma A; Van Stavern GP J Neuroophthalmol; 2014 Dec; 34(4):331-5. PubMed ID: 25000261 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of 2D FLAIR hyperintensity of the optic nerve and optic nerve head and visual parameters in idiopathic intracranial hypertension. Orlowski H; Sharma A; Alvi F; Arora J; Parsons MS; Van Stavern GP J Neuroradiol; 2022 Mar; 49(2):193-197. PubMed ID: 34688702 [TBL] [Abstract][Full Text] [Related]
10. Unilateral Papilledema in Idiopathic Intracranial Hypertension: A Case Series. Swinkin E; Jabehdar Maralani P; Sundaram AN Can J Neurol Sci; 2022 Mar; 49(2):278-281. PubMed ID: 33888167 [TBL] [Abstract][Full Text] [Related]
11. Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema. Farrokhi Y; Sharif Kashani S; Aghsaei Fard M; Pakdel F; Yadegari S Clin Neurol Neurosurg; 2019 Sep; 184():105376. PubMed ID: 31176474 [TBL] [Abstract][Full Text] [Related]
12. Papilledema: A Review of the Pathophysiology, Imaging Findings, and Mimics. Guarnizo A; Albreiki D; Cruz JP; Létourneau-Guillon L; Iancu D; Torres C Can Assoc Radiol J; 2022 Aug; 73(3):557-567. PubMed ID: 35044276 [TBL] [Abstract][Full Text] [Related]
13. Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension. Bicakci K; Bicakci S; Aksungur E Acta Neurol Scand; 2006 Sep; 114(3):193-7. PubMed ID: 16911348 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the optic nerve stiffness and optic nerve sheath diameter in idiopathic intracranial hypertension patients after the resolution of papilledema. Kaya FS; Bayram E; İnci E Neurol Sci; 2021 Dec; 42(12):5165-5170. PubMed ID: 33788047 [TBL] [Abstract][Full Text] [Related]